🇺🇸 Levonorgestrel and ethinylestradiol in United States

9 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Window: 22 April 2025 – 22 April 2026
Total reports: 9

Most-reported reactions

Arthralgia — 1 report (11.11%)
Diarrhoea — 1 report (11.11%)
Erythema Nodosum — 1 report (11.11%)
Fatigue — 1 report (11.11%)
Haemorrhoids — 1 report (11.11%)
Pulmonary Embolism — 1 report (11.11%)
Rash Erythematous — 1 report (11.11%)
Vomiting — 1 report (11.11%)
Weight Decreased — 1 report (11.11%)

Source database →

Other Contraception / Reproductive Health approved in United States

Frequently asked questions

Is Levonorgestrel and ethinylestradiol approved in United States?

Levonorgestrel and ethinylestradiol does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Levonorgestrel and ethinylestradiol in United States?

IVI Madrid is the originator. The local marketing authorisation holder may differ — check the official source linked above.